Expertise in
4
conditions

Rohini A. Sharma

Du Cane Road, 
London, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Du Cane Road, 
London, ENG, GB 

Overview

Rohini Sharma practices practicing medicine in London, United Kingdom.

Ms. Sharma is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Neuroendocrine Tumor, Perioral Dermatitis, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

She is actively involved in clinical research, co-authoring 173 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

Du Cane Road, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Epigenetic Modification of Somatostatin Receptor-2 to Improve Therapeutic Outcome With Lutathera in Patients With Metastatic Neuroendocrine Tumours.
The Epigenetic Modification of Somatostatin Receptor-2 to Improve Therapeutic Outcome With Lutathera in Patients With Metastatic Neuroendocrine Tumours.
Enrollment Status: Recruiting
Publish Date: November 24, 2025
Intervention Type: Drug, Radiation
Study Drug: ASTX727
Study Phase: Phase 1
A Phase Ib Study of Itacitinib, a JAK1 Inhibitor, in Advanced Hepatocellular Carcinoma
A Phase Ib Study of Itacitinib, a JAK1 Inhibitor, in Advanced Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: May 04, 2026
Intervention Type: Drug
Study Drug: Itacitinib (INCB039110)
Study Phase: Phase 1
A Phase II Assessment of the Safety and Efficacy of TheraSphere® Selective Internal Radiation Therapy (SIRT) in the Treatment of Metastatic (Liver) Neuroendocrine Tumours (NETs)
A Phase II Assessment of the Safety and Efficacy of TheraSphere® Selective Internal Radiation Therapy (SIRT) in the Treatment of Metastatic (Liver) Neuroendocrine Tumours (NETs)
Enrollment Status: Completed
Publish Date: January 14, 2026
Intervention Type: Radiation
Study Phase: Phase 2
A Phase Ib Study of Pembrolizumab Following Trans-Arterial Chemoembolization in Primary Liver Carcinoma
A Phase Ib Study of Pembrolizumab Following Trans-Arterial Chemoembolization in Primary Liver Carcinoma
Enrollment Status: Completed
Publish Date: March 06, 2025
Intervention Type: Drug, Combination product
Study Drug: Pembrolizumab
Study Phase: Phase 1/Phase 2
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
Enrollment Status: Completed
Publish Date: November 08, 2023
Intervention Type: Device
Study Phase: Not Applicable
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
Enrollment Status: Completed
Publish Date: July 13, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

173 Total Publications

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: December 29, 2025

Frequently Asked Questions about Rohini A. Sharma

Is Rohini A. Sharma a top-rated expert for Liver Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Rohini A. Sharma is classified as an Distinguished expert for Liver Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rohini A. Sharma participate in research or clinical trials?

Yes. Rohini A. Sharma has published 173 articles and abstracts on conditions like Liver Cancer. You can view a list of Rohini A. Sharma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sharma's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile